6:04 AM ET
8-K
Investor Meeting
Humana Investor Meeting
Humana reaffirmed its FY 2026 adjusted EPS guidance of at least $9.00 and provided an update on its 2027 Medicare Advantage Star Ratings from CMS. The company achieved its goal of Top Quartile results, which it expects will provide a one-time financial benefit in 2028 to be used for investments and shareholder returns.
- Counterparty
- CMS
- Term
- FY 2026